October 17, 2023 | Vensana Capital® Portfolio News

Evident Vascular Exits Stealth with $35 Million Series A Funding to Develop Vascular Imaging Platform

21

Novel FDA PMA & de novo 510k approvals

60

U.S. Commercial Product Launches

39

Level I Clinical Trials

31

Strategic Financings

31

Exits by IPO or M&A